MULTIPLE SCLEROSIS JOURNAL, vol.21, no.9, pp.1159-1171, 2015 (SCI-Expanded)
Background: The results of head-to-head comparisons of injectable immunomodulators (interferon , glatiramer acetate) have been inconclusive and a comprehensive analysis of their effectiveness is needed.